Didier B.
- Country
- France
- Department
- Dermatology
Research Overview
- Long-Term Safety and Efficacy Evaluation of Litifilimab (BIIB059) in Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus
- Evaluation of Hydroxychloroquine Sulfate in Patients with Isolated Cutaneous Mastocytosis or Indolent Systemic Mastocytosis with Skin Involvement
- Evaluation of Long-Term Safety and Efficacy of Alpelisib in Patients with PIK3CA-Related Overgrowth Spectrum (PROS) Following Participation in Study CBYL719F12002
Data & Insights
Has run more than one trial at 58 of 115 partner sites.
Specializations
Cutaneous Lupus Research
The investigator specializes in treating cutaneous lupus erythematosus (CLE), with particular focus on its subacute and chronic forms. Their research encompasses evaluating novel therapeutic approaches for patients with active disease manifestations.
- Subacute Cutaneous Lupus Erythematosus (SCLE)
- Chronic Cutaneous Lupus Erythematosus (CCLE)
- Antimalarial-Refractory Cases
Their work includes investigation of targeted therapies for patients who are refractory or intolerant to conventional treatments.
Mastocytosis Studies
The investigator conducts research in mastocytosis, focusing on both isolated cutaneous and systemic manifestations. Their work includes evaluation of therapeutic interventions for mast cell activation symptoms.
- Cutaneous Mastocytosis
- Indolent Systemic Mastocytosis
- Mast Cell Activation Management
Their research emphasizes treatment approaches for symptoms such as pruritus and flush in mastocytosis patients.
Genetic Disorders
The investigator studies PIK3CA-Related Overgrowth Spectrum (PROS), a rare genetic condition. Their research focuses on evaluating long-term therapeutic interventions for this disorder.
- PIK3CA Mutations
- Overgrowth Disorders
- Long-term Treatment Safety
Their work includes assessment of targeted therapies for patients with confirmed PROS diagnosis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.